Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: BlueCheap who wrote (756)	1/11/2000 5:11:00 PM
From: Bucky Katt	Read Replies (3) \| Respond to of 48461

Here is some pretty big JMAR/biotek news, and a Rat since 1.50>> JMAR Technologies Inc. (Nasdaq:JMAR - news), announced today that its JMAR Precision Systems (JPSI) division has received orders valued at approximately $1.8 million from a leading DNA biochip company for several micro-positioning lithography alignment systems. These systems will enable the fabrication of biomedical products targeted at improving the diagnosis, monitoring and treatment of many diseases. DNA biochips are also being used for managing genetic information that can contribute to the study of the human aging process. According to the Oct. 25, 1999 ''Business Week'' magazine, surveys by brokerage houses and market-research firms indicate an immediate market for biochips of about $1 billion -- with the potential to expand to $40 billion in the next decade. This increase should generate substantial growth opportunities for equipment and systems makers in this market. ''We are extremely pleased with the growing demand from the biotechnology industry for our precision products,'' commented John S. Martinez, Ph.D. JMAR's chairman and chief executive officer. ''The biotech industry, long overshadowed by Silicon Valley, is now beginning to incorporate key semiconductor manufacturing techniques to accelerate the pace of its product introductions. The adaptation to the biochip market of JMAR's precision positioning, alignment and lithography technologies is a natural spin-off from our current semiconductor equipment product lines. Yep, I agree!!